Free Trial

Comera Life Sciences (CMRAW) Competitors

CMRAW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Comera Life Sciences stock or one of its competitors? The main competitors of Comera Life Sciences include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Comera Life Sciences vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Comera Life Sciences (NASDAQ:CMRAW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Comera Life Sciences N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Comera Life Sciences. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Comera Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat Comera Life Sciences' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
Comera Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

Summary

180 Life Sciences beats Comera Life Sciences on 2 of the 3 factors compared between the two stocks.

Get Comera Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRAW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CMRAW vs. The Competition

MetricComera Life SciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$131.03M$5.51B$9.31B
Dividend YieldN/A3.74%4.25%4.09%
P/E RatioN/A3.6028.1219.69
Price / SalesN/A4,246.15439.46100.25
Price / CashN/A13.1935.5357.53
Price / BookN/A42.108.235.67
Net IncomeN/A-$92.15M$3.23B$257.51M

Comera Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CMRAW
Comera Life Sciences
N/AN/AN/AN/A$0.00$1.00M0.002
ATNFW
180 Life Sciences
N/A$0.01
-2.4%
N/A-25.0%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
-22.0%
N/AN/A$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.10
-7.8%
N/A+121.1%$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.78
+7.9%
N/A-28.0%$0.00$585.60M0.004Gap Up
AMPE
Ampio Pharmaceuticals
N/A$0.00
-96.3%
N/A-88.9%$0.00N/A0.0020Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/A-56.1%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.11
+21.5%
N/AN/A$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.01
flat
N/AN/A$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.07
flat
N/A-69.9%$0.00N/A0.008News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:CMRAW) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners